Medical Device Submissions Guidebook: 510(k) & De Novo
Enjoy this new in-depth resource with timely and expert guidance on the 510(k) and De Novo submission process! The comprehensive guide will help regulatory professionals navigate the complexities of the 510(k) and De Novo submission processes as they bring their organizations latest technologies to market.
Starting at $200 for AdvaMed® members and packed with expert insights, best practices, and step-by-step guidance, this Guidebook will help streamline your submissions application, avoid common pitfalls, and ensure compliance with FDA requirements. Access the Guidebook today!
Related Reading
News / Diagnostics / Digital Health / Government & Legislative Affairs / Regulatory Affairs
AdvaMed Releases “AI Policy Roadmap” to Guide Congress and Federal Agencies
April 22, 2025
Washington, D.C.—AdvaMed, the Medtech Association, today released its “AI Policy Roadmap,” a detailed policy outline for Congress and the federal agencies with jurisdiction over medtech to consider in promoting the next era of artificial intelligence-enabled medical and digital health technologies to provide patients and clinicians transformative new tools to aid in diagnosis and treatment.
News / Coverage & Payment / Government & Legislative Affairs / Regulatory Affairs
AdvaMed Congratulates Dr. Oz on his Confirmation as CMS Administrator
April 3, 2025
Washington, D.C.– AdvaMed®, the Medtech Association, today released the following statement from President and CEO Scott Whitaker on the U.S. Senate’s confirmation of Dr. Mehmet Oz to serve as Administrator of the U.S. Centers for Medicare and Medicaid Services.
Blog / Coverage & Payment / Diagnostics / Global & Trade / Government & Legislative Affairs / Regulatory Affairs / Small Business
AdvaMed®’s Medical Innovation Agenda for the 119th Congress
March 28, 2025
AdvaMed®’s medtech priorities for the 119th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.
Resource / Compliance / Global & Trade / Regulatory Affairs
State of the Nation 2025: Global Medical Device Recall Index Report
March 27, 2025
Download Sedgwick’s Global Medical Device Recall Report for key insights on compliance, regulations, and global recall trends. Members only.
Event / Compliance / Coverage & Payment / Regulatory Affairs
Richardson Waiver Repeal: What it Means for Medtech
Now On Demand
Sidley Austin, joined by HPA, will lead a program examining the impact of HHS repealing the so-called “Richardson Waiver”, including its history, how it could impact the activities of the U.S. Department of Health and Humans Services (HHS), what it all means for medtech and its patients.
News / Government & Legislative Affairs / Regulatory Affairs
AdvaMed® Congratulates Dr. Makary on his Confirmation as FDA Commissioner
March 26, 2025
Washington, D.C.– AdvaMed®, the Medtech Association, today released the following statement from President and CEO Scott Whitaker on the U.S. Senate’s confirmation of Dr. Marty Makary to serve as commissioner of the U.S. Food and Drug Administration.
Resource / Coverage & Payment / Diagnostics / Global & Trade / Government & Legislative Affairs / Health Equity / Legal / Regulatory Affairs / Small Business
The Medical Innovation Agenda for the 119th Congress
March 13, 2025
AdvaMed®’s medtech priorities for the 119th Congress highlight opportunities to address the most important issues facing patients and the medical technology industry today.
Resource / Digital Health / Regulatory Affairs
Connected Medical Devices
February 25, 2025
This white paper, “Connected Medical Devices”, explores the transformative impact of integrating Bluetooth Low Energy (BLE), mobile apps, cloud platforms, and AI/ML into medical devices. It highlights the benefits of real-time data exchange, remote monitoring, and enhanced clinical decision-making while addressing challenges such as security, FDA compliance, and data management. The document includes a case study on an implantable neural stimulator, outlines key design considerations, and discusses mobile and cloud-based platforms for connected healthcare solutions. Developed by Sunrise Labs, the paper provides insights into engineering best practices for next-generation medical devices.